Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1980 1
1981 1
1982 1
1983 2
1989 4
1990 3
1991 2
1992 3
1993 1
1994 5
1995 2
1996 1
1997 1
1998 6
1999 2
2000 1
2001 3
2002 3
2003 1
2004 6
2005 4
2006 2
2007 6
2008 5
2009 6
2010 4
2011 4
2012 4
2013 2
2014 4
2015 9
2016 10
2017 10
2018 13
2019 9
2020 12
2021 5
2022 11
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

160 results
Results by year
Filters applied: . Clear all
Page 1
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
Capasso A, Lang J, Pitts TM, Jordan KR, Lieu CH, Davis SL, Diamond JR, Kopetz S, Barbee J, Peterson J, Freed BM, Yacob BW, Bagby SM, Messersmith WA, Slansky JE, Pelanda R, Eckhardt SG. Capasso A, et al. Among authors: bagby sm. J Immunother Cancer. 2019 Feb 8;7(1):37. doi: 10.1186/s40425-019-0518-z. J Immunother Cancer. 2019. PMID: 30736857 Free PMC article.
Myositis autoantibodies: recent perspectives.
Riddell V, Bagby S, McHugh N. Riddell V, et al. Among authors: bagby s. Curr Opin Rheumatol. 2020 Nov;32(6):548-552. doi: 10.1097/BOR.0000000000000742. Curr Opin Rheumatol. 2020. PMID: 32890028 Review.
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.
Marín-Jiménez JA, Capasso A, Lewis MS, Bagby SM, Hartman SJ, Shulman J, Navarro NM, Yu H, Rivard CJ, Wang X, Barkow JC, Geng D, Kar A, Yingst A, Tufa DM, Dolan JT, Blatchford PJ, Freed BM, Torres RM, Davila E, Slansky JE, Pelanda R, Eckhardt SG, Messersmith WA, Diamond JR, Lieu CH, Verneris MR, Wang JH, Kiseljak-Vassiliades K, Pitts TM, Lang J. Marín-Jiménez JA, et al. Among authors: bagby sm. Front Immunol. 2021 Mar 29;12:607282. doi: 10.3389/fimmu.2021.607282. eCollection 2021. Front Immunol. 2021. PMID: 33854497 Free PMC article.
Cabozantinib as a second-line treatment option in hepatocellular carcinoma.
D'Angelo A, Sobhani N, Bagby S, Casadei-Gardini A, Roviello G. D'Angelo A, et al. Among authors: bagby s. Expert Rev Clin Pharmacol. 2020 Jun;13(6):623-629. doi: 10.1080/17512433.2020.1767591. Epub 2020 May 22. Expert Rev Clin Pharmacol. 2020. PMID: 32394749 Review.
Chronic Kidney Disease: A Life Course Health Development Perspective.
Brophy PD, Charlton JR, Bryan Carmody J, Reidy KJ, Harshman L, Segar J, Askenazi D, Shoham D, Bagby SP. Brophy PD, et al. Among authors: bagby sp. 2017 Nov 21. In: Halfon N, Forrest CB, Lerner RM, Faustman EM, editors. Handbook of Life Course Health Development [Internet]. Cham (CH): Springer; 2018. 2017 Nov 21. In: Halfon N, Forrest CB, Lerner RM, Faustman EM, editors. Handbook of Life Course Health Development [Internet]. Cham (CH): Springer; 2018. PMID: 31314288 Free Books & Documents. Review.
Ecology and molecular targets of hypermutation in the global microbiome.
Roux S, Paul BG, Bagby SC, Nayfach S, Allen MA, Attwood G, Cavicchioli R, Chistoserdova L, Gruninger RJ, Hallam SJ, Hernandez ME, Hess M, Liu WT, McAllister TA, O'Malley MA, Peng X, Rich VI, Saleska SR, Eloe-Fadrosh EA. Roux S, et al. Among authors: bagby sc. Nat Commun. 2021 May 24;12(1):3076. doi: 10.1038/s41467-021-23402-7. Nat Commun. 2021. PMID: 34031405 Free PMC article.
160 results